The fact
The French biopharmaceutical firm, listed on Euronext, seeks a strategic partner for its treatments.
Shareholders await updates on ongoing clinical trials for masitinib.
Click the link to read an article on the topic:
The French biopharmaceutical firm, listed on Euronext, seeks a strategic partner for its treatments.
Shareholders await updates on ongoing clinical trials for masitinib.